OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A broad and potent neutralization epitope in SARS-related coronaviruses
Meng Yuan, Xueyong Zhu, Wanting He, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 29
Open Access | Times Cited: 56
Meng Yuan, Xueyong Zhu, Wanting He, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 29
Open Access | Times Cited: 56
Showing 26-50 of 56 citing articles:
Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
Vaccine (2024) Vol. 42, Iss. 20, pp. 125980-125980
Open Access | Times Cited: 2
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
Vaccine (2024) Vol. 42, Iss. 20, pp. 125980-125980
Open Access | Times Cited: 2
Structural review of SARS-CoV-2 antiviral targets
Wen Cui, Yinkai Duan, Gao Yan, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1301-1321
Closed Access | Times Cited: 2
Wen Cui, Yinkai Duan, Gao Yan, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1301-1321
Closed Access | Times Cited: 2
Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD
Vincenzo Tragni, Ivan Mercurio, Diletta Pia Paoletti, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 6
Vincenzo Tragni, Ivan Mercurio, Diletta Pia Paoletti, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Open Access | Times Cited: 6
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 6
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 6
Massively-multiplexed epitope mapping techniques for viral antigen discovery
Diya Hu, Aaron T. Irving
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Diya Hu, Aaron T. Irving
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity
Meng Yuan, Ziqi Feng, Huibin Lv, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113194-113194
Open Access | Times Cited: 6
Meng Yuan, Ziqi Feng, Huibin Lv, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113194-113194
Open Access | Times Cited: 6
Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2
Yupeng Feng, Meng Yuan, John M. Powers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Yupeng Feng, Meng Yuan, John M. Powers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Identification and validation of ferroptosis-related genes in patients infected with dengue virus: implication in the pathogenesis of DENV
Jinlian Li, Xipeng Yan, Bin Li, et al.
Virus Genes (2023) Vol. 59, Iss. 3, pp. 377-390
Open Access | Times Cited: 5
Jinlian Li, Xipeng Yan, Bin Li, et al.
Virus Genes (2023) Vol. 59, Iss. 3, pp. 377-390
Open Access | Times Cited: 5
Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
Anamika Patel, Sanjeev Kumar, Lilin Lai, et al.
Structure (2023) Vol. 31, Iss. 7, pp. 801-811.e5
Open Access | Times Cited: 5
Anamika Patel, Sanjeev Kumar, Lilin Lai, et al.
Structure (2023) Vol. 31, Iss. 7, pp. 801-811.e5
Open Access | Times Cited: 5
Efficacy of a Stable Broadly Protective Subunit Vaccine Platform Against Sars-Cov-2 Variants of Concern
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
(2024)
Closed Access | Times Cited: 1
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
(2024)
Closed Access | Times Cited: 1
Development of Glycan-masked SARS-CoV-2 RBD vaccines against SARS-related coronaviruses
Zuxin Liang, Chunhui Li, Xiaohua Gong, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012599-e1012599
Open Access | Times Cited: 1
Zuxin Liang, Chunhui Li, Xiaohua Gong, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012599-e1012599
Open Access | Times Cited: 1
Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012704-e1012704
Open Access | Times Cited: 1
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012704-e1012704
Open Access | Times Cited: 1
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron
Anamika Patel, Sanjeev Kumar, Lilin Lai, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113150-113150
Open Access | Times Cited: 3
Anamika Patel, Sanjeev Kumar, Lilin Lai, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113150-113150
Open Access | Times Cited: 3
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant-specific neutralizing antibodies
Trinity Zang, Edmund Osei Kuffour, Viren A. Baharani, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 51
Open Access | Times Cited: 2
Trinity Zang, Edmund Osei Kuffour, Viren A. Baharani, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 51
Open Access | Times Cited: 2
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses
Felicitas Ruiz, Will Foreman, Michelle M. Lilly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Felicitas Ruiz, Will Foreman, Michelle M. Lilly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A benchmark for evaluation of structure-based online tools for antibody-antigen binding affinity
Xu Jiayi, Jianting Gong, Xiaochen Bo, et al.
Biophysical Chemistry (2024) Vol. 311, pp. 107253-107253
Closed Access
Xu Jiayi, Jianting Gong, Xiaochen Bo, et al.
Biophysical Chemistry (2024) Vol. 311, pp. 107253-107253
Closed Access
A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants
Marisa Yang, Tom Z. Yuan, Kara Y. Chan, et al.
Antibody Therapeutics (2024) Vol. 7, Iss. 2, pp. 164-176
Open Access
Marisa Yang, Tom Z. Yuan, Kara Y. Chan, et al.
Antibody Therapeutics (2024) Vol. 7, Iss. 2, pp. 164-176
Open Access
Engineering a SARS-CoV-2 vaccine targeting the RBD cryptic-face via immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Engineering a SARS-CoV-2 Vaccine Targeting the Receptor-Binding Domain Cryptic-Face via Immunofocusing
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
ACS Central Science (2024) Vol. 10, Iss. 10, pp. 1871-1884
Open Access
Theodora U. J. Bruun, Jonathan Do, Payton A. Weidenbacher, et al.
ACS Central Science (2024) Vol. 10, Iss. 10, pp. 1871-1884
Open Access
Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses
Felicitas Ruiz, William Foreman, Michelle M. Lilly, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012650-e1012650
Open Access
Felicitas Ruiz, William Foreman, Michelle M. Lilly, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 10, pp. e1012650-e1012650
Open Access
Coronaviruses: Pandemic SARS-CoV-2
Benjamin J. Cowling, Sook‐San Wong
Springer eBooks (2024), pp. 1-79
Closed Access
Benjamin J. Cowling, Sook‐San Wong
Springer eBooks (2024), pp. 1-79
Closed Access
IgG1 versus IgG3: influence of antibody-specificity and allotypic variance on virus neutralization efficacy
Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Somanath Kallolimath, Lin Sun, Roman Palt, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS‐CoV‐2
Hyung J. Kwon, Jun Zhang, Matina Kosikova, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 1
Hyung J. Kwon, Jun Zhang, Matina Kosikova, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 1
Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants
Kan Li, Richard H.C. Huntwork, Gillian Q. Horn, et al.
Journal of Virology (2023) Vol. 97, Iss. 12
Open Access | Times Cited: 1
Kan Li, Richard H.C. Huntwork, Gillian Q. Horn, et al.
Journal of Virology (2023) Vol. 97, Iss. 12
Open Access | Times Cited: 1
